Biotechnology industry organization | Trends In Biotechnology Industry

SUBSCRIBE ASIA DIGEST

Wednesday, September 8, 2010

SEARCH

BIO AUSTRALIA

BIO CHINA

BIO INDIA

BIO INDONESIA

BIO JAPAN

BIO KOREA

BIO MALAYSIA

BIO NEW ZEALAND

BIO PHILIPPINES

BIO SINGAPORE

BIO TAIWAN

BIO THAILAND

BIOTECH SPOTLIGHT

	Phosphagenics strengthens board to boost commercialization

	Australian biotechnology company, Phosphagenics has appointed Mr Stuart James, Dr Sandra Webb and Mr Don Clarke as non-executive directors to formulate and facilitate the implementation of strategies to commercialize the companys R&D pipeline

	Sudhir Kant joins Avesthagen

	Mr Kant was earlier heading the Indian operations of Millipore India, a wholly-owned subsidiary of the Millipore Group

TODAY'S NEWS

	Uncontrolled asthma increases hospitalization in Japan, US

	Zenox Lifesciences aims at $21 mn turnover by 2012-13

	Chugai seeks MHLW approval of anti-cancer drug, Xeloda

	Elder Pharma gets awards

	GSK comments on Avandia controversy

	Taiwan's DoH to decide fate of diet pill

	Advertisement

	Digital Mag
Issue: Aug, 2010 Current Issue View / Download
	Top Story
Are biofuels poised for a leap?

PEOPLE

Gene Logic announces appointment of Norrie Russell as President

The new President to play a major role in the progress of Ocimum's Research as a Service (RaaS) offerings

Phosphagenics strengthens board to boost commercialization

Australian biotechnology company, Phosphagenics has appointed Mr Stuart James, Dr Sandra Webb and Mr Don Clarke as non-executive directors to formulate and facilitate the implementation of strategies to commercialize the companys R&D pipeline

Sudhir Kant joins Avesthagen

Mr Kant was earlier heading the Indian operations of Millipore India, a wholly-owned subsidiary of the Millipore Group

'India to get high priority in our international strategy'

The UK MHRA looks at regulations pertaining to medicines, devices, nanotechnology and tissue engineering. Prof. Kent Woods, Chief Executive, UK MHRA, discusses about the agency's India strategy.

Avexa appoints new Non-Executive Director

Avexa Limited, a Melbourne-based biotechnology company with a focus on research and development of anti-infectives, has announced the appointment of Mr Iain Kirkwood to the Avexa Board as a Non-Executive Director

The idea is to take food and land use out of equation: Mr David Tulauskas

In an interview with BioSpectrum, Mr David Tulauskas, Director of Public Policy, GM APAC, China, shares his views on GMs biofuels initiatives in Asia

Avesthagen brings Mr Jacques Vincent onboard

Avesthagen, Indias knowledge-based life sciences company, has appointed Mr Jacques Vincent as a member of the company's Board of Directors. Mr Vincent joins the Board in his personal capacity as an expert in the food and science industry

Mr BN Manohar becomes the CEO of Stempeutics

Stempeutics Research, a leading stem cell company developing stem cell-based medicinal products in India, has promoted Mr BN Manohar, formerly President as the Chief Executive Officer of the company.

Novavax appoints Dr Gregory Glenn as CSO

Novavax, a clinical-stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide, announced the appointment of Dr Gregory Glenn, as the company's Chief Scientific Officer.

Siemens Healthcare appoints Dr John Glaser as CEO of Health IT Business

Siemens Healthcare, a leading supplier to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids, has appointed Dr John Glaser, as CEO of the Health Services Business Unit


	Advertisement



		CyberMedia Network Websites [Voice&Data] [PCQuest] [CIOL] [Dataquest] [Living Digital] [IDC India] [DQ Channels] [The DQweek] [DARE] [CyberMedia Events] [CyberMedia Digital] [Cyber Astro] [CyberMedia India] [Global Services] [BioSpectrum]



		Copyrights are reserved for BioSpectrum ; Designed by : Altered Black